La vaccination contre la maladie de Newcastle chez le poulet (Gallus gallus)

Biotechnologie, Agronomie, Société et Environnement 01/2009;
Source: DOAJ


Vaccination against Newcastle disease in chickens. Newcastle Disease (ND), also termed fowl pest, is a highly contagious and devastating disease in poultry. It is induced by an avian paramyxoviruses serotype 1, named ND virus (NDV). NDV has been shown to be able to infect over 200 different species of birds but the virulence of this virus and clinical signs of ND vary largely with both host and strain of virus. Virulent strains require to be reported to the World Organisation for Animal Health (OIE) and outbreaks result in strict embargoes for the trade of avian products among countries. Control of ND primarily consists of vaccination of flocks and culling of infected or likely infected birds. At the present time, vaccination programs for NDV include the use of either inactivated (killed) or attenuated (live) vaccines to induce protective immunity while producing minimal adverse reactions in birds. Live viruses of low virulence (apathogenic, lentogenic) or of moderate virulence (mesogenic) are used depending on the disease situation and the regulations. Nevertheless, vaccination schedules might vary among poultry breeds. Generally, post-vaccination serology is used to confirm successful application of vaccine and an adequate immune response by the bird. However, it is well recognized that many chickens with low or no antibody titer are protected in challenge experiments and that present vaccination schedules do not protect well against viral re-excretion. One of the most important considerations affecting vaccination programs is the level of maternal immunity in young chickens, which may vary considerably from farm to farm and among individual chickens. Additionally, vaccine strains are phylogenetically different from circulating virulent strains. Then, new vaccines candidates are investigated in laboratory to improve the efficacy of conventional commercial vaccines while new tools of immunity measure are developed to increase the understanding of the protective immune response against NDV.

Download full-text


Available from: Bénédicte Lambrecht, Sep 30, 2015
149 Reads
  • Journal of Interferon & Cytokine Research 09/1999; 19(8):881-5. DOI:10.1089/107999099313406 · 2.00 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Strains of Newcastle disease virus (NDV) can be separated into genotypes based on genome differences even though they are antigenically considered to be of a single serotype. It is widely recognized that an efficacious Newcastle disease (ND) vaccine made with any NDV does induce protection against morbidity and mortality from a virulent NDV challenge. However, those ND vaccines do not protect vaccinates from infection and viral shed from such a challenge. Vaccines prepared from ND viruses corresponding to five different genotypes were compared to determine if the phylogenetic distance between vaccine and challenge strain influences the protection induced and the amount of challenge virus shed. Six groups of 4-week-old specific pathogen-free Leghorn chickens were given oil-adjuvanted vaccines prepared from one of five different inactivated ND viruses including strains B1, Ulster, CA02, Pigeon84, Alaska 196, or an allantoic fluid control. Three weeks post-vaccination, serum was analyzed for antibody content using a hemagglutination inhibition assay against each of the vaccine antigens and a commercial NDV ELISA. After challenge with virulent CA02, the birds were examined daily for morbidity and mortality and were monitored at selected intervals for virus shedding. All vaccines except for the control induced greater than 90% protection to clinical disease and mortality. The vaccine homologous with the challenge virus reduced oral shedding significantly more than the heterologous vaccines. NDV vaccines formulated to be phylogenetically closer to potential outbreak viruses may provide better ND control by reducing virus transmission from infected birds.
    Vaccine 11/2007; 25(41):7238-46. DOI:10.1016/j.vaccine.2007.07.017 · 3.62 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: An immune complex (IC), composed of antigenic subunits of the Newcastle disease virus (NDV) and specific polyclonal allogeneic antibodies, was used to protect chickens against NDV. Antibodies in the IC were chicken immunoglobulin G. The antibody:antigen ratio in IC was 2.03. The IC was prepared at equivalence by direct mixing of NDV-infected allantoic fluid, treated with Triton X-100, and chicken anti-NDV serum. In order to bind NDV antigenic subunits to specific antibodies, previous isolation and purification of antigen is not required. Chickens were immunized with 1 mg IC, containing 0.3788 mg of viral antigens. The IC, prepared in the form of an oil-emulsion, was administered intramuscularly. The IC generated high levels of anti-NDV antibodies and successfully protected chickens against live virus challenge. Therefore, the IC could be recommended as a safe and environmentally convenient vaccine.
    Vaccine 02/1993; 11(6):655-9. DOI:10.1016/0264-410X(93)90312-L · 3.62 Impact Factor